研究单位：[1]Hangzhou Endonom Medtech Co., Ltd.[2]Beijing Friendship Hospital, Capital Medical University,Beijing,China[3]Chinese People''s Liberation Army General Hospital,Beijing,China[4]Peking University People''s Hospital,Beijing,China[5]Xiangya Hospital of Central South University,Changsha,China[6]West China Hospital of Sichuan University,Chengdu,China[7]The First Affiliated Hospital of Fujian Medical University,Fuzhou,China[8]Guangdong Provincial People''s Hospital,Guangzhou,China[9]Hainan Provincial People''s Hospital,Haikou,China[10]Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,China[11]The First Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,China[12]Anhui Provincial Hospital,Hefei,China[13]The First Affiliated Hospital of Kunming Medical College,Kunming,China[14]Liuzhou Workers'' Hospital,Liuzhou,China[15]The Second Affiliated Hospital of Nanchang University,Nanchang,China[16]Jiangsu Provincial People''s Hospital,Nanjing,China[17]The First Affiliated Hospital of Guangxi Medical University,Nanning,China[18]The Ninth People''s Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai,China[19]Zhongshan Hospital Affiliated to Fudan University,Shanghai,China[20]The First Hospital of Hebei Medical University,Shijia Zhuang,China[21]Tianjin Medical University General Hospital,Tianjin,China[22]The First Affiliated Hospital of the Fourth Military Medical University,Xi''an,China[23]Yantai Yuhuangding Hospital,Yantai,China[24]First Affiliated Hospital of Zhengzhou University,Zhengzhou,China[25]Henan Provincial People''s Hospital,Zhengzhou,China
研究目的：
A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of Fabulous Stent Graft System manufactured by Hangzhou Endonom Medtech Co., Ltd. for Stanford B Aortic Dissection.
